For metabolic reprogramming in the context of CRC, the most critical oncogenes are MYC together with HIF, the PI3K/AKT/mTOR axis and KRAS as well as BRAF with their interconnected, associated signaling pathways and the tumor suppressor p53. This evidence concerns the gene MYC and colorectal carcinoma.